Regulatory Risk Management in Nanotechnology: Proactive Steps to Take Now for Security in the Future
September 27, 2007
Foley is proud to introduce its Nanotechnology Web conference series, The Business of Nanotech. This series is designed to keep participants up-to-date on the latest developments in the field of nanotechnology and the impact of those developments across industries.
In this, our inaugural program, we discussed Regulatory Risk Management in Nanotechnology: Proactive Steps to Take Now for Security in the Future. Specific topics included:
- The future prospects for U.S. Environmental Protection Agency (EPA) and U.S. Food and Drug Administration (FDA) regulatory activity
- Developments in self-regulatory initiatives involving industry and consumer groups
- The effects of activist opposition on the regulatory process
- Potential paths forward for the regulatory process
- Regulatory initiatives in key international markets
Speakers
- Val Giddings, President and CEO, PrometheusAB
- Mark Mansour, Partner, Foley
- Michael R. Pontrelli, Partner, Foley
People
Related Insights
December 12, 2025
Health Care Law Today
Eleventh Circuit Hears Oral Argument in Landmark Constitutional Challenge to False Claims Act’s Qui Tam Provisions
On December 12, the U.S. Court of Appeals for the Eleventh Circuit heard oral argument in U.S. ex rel. Zafirov v. Florida Medical…
December 11, 2025
Foley Viewpoints
Antitrust Risks and Compliance Strategies in Intellectual Property Portfolio Management
This article analyzes how intellectual property portfolio management can simultaneously promote innovation and present potential…
December 11, 2025
Foley Viewpoints
CARB Releases Proposed Regulations for SB 261 and 253
On December 9, 2025, the California Air Resources Board (CARB) released its proposed regulatory text for the initial regulations…